875 related articles for article (PubMed ID: 9267033)
1. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
Davies SW; Turmaine M; Cozens BA; DiFiglia M; Sharp AH; Ross CA; Scherzinger E; Wanker EE; Mangiarini L; Bates GP
Cell; 1997 Aug; 90(3):537-48. PubMed ID: 9267033
[TBL] [Abstract][Full Text] [Related]
2. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Gourfinkel-An I; Cancel G; Duyckaerts C; Faucheux B; Hauw JJ; Trottier Y; Brice A; Agid Y; Hirsch EC
Neuroreport; 1998 Jun; 9(8):1823-6. PubMed ID: 9665608
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
4. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.
Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA
Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478
[TBL] [Abstract][Full Text] [Related]
5. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
Davies SW; Beardsall K; Turmaine M; DiFiglia M; Aronin N; Bates GP
Lancet; 1998 Jan; 351(9096):131-3. PubMed ID: 9439509
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
[TBL] [Abstract][Full Text] [Related]
7. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation.
Morton AJ; Lagan MA; Skepper JN; Dunnett SB
J Neurocytol; 2000 Sep; 29(9):679-702. PubMed ID: 11353291
[TBL] [Abstract][Full Text] [Related]
8. Transgenic models of Huntington's disease.
Sathasivam K; Hobbs C; Mangiarini L; Mahal A; Turmaine M; Doherty P; Davies SW; Bates GP
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):963-9. PubMed ID: 10434294
[TBL] [Abstract][Full Text] [Related]
9. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
Wanderer J; Morton AJ
Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
[TBL] [Abstract][Full Text] [Related]
10. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.
Turmaine M; Raza A; Mahal A; Mangiarini L; Bates GP; Davies SW
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8093-7. PubMed ID: 10869421
[TBL] [Abstract][Full Text] [Related]
11. Neurological abnormalities in a knock-in mouse model of Huntington's disease.
Lin CH; Tallaksen-Greene S; Chien WM; Cearley JA; Jackson WS; Crouse AB; Ren S; Li XJ; Albin RL; Detloff PJ
Hum Mol Genet; 2001 Jan; 10(2):137-44. PubMed ID: 11152661
[TBL] [Abstract][Full Text] [Related]
12. Formation of polyglutamine inclusions in non-CNS tissue.
Sathasivam K; Hobbs C; Turmaine M; Mangiarini L; Mahal A; Bertaux F; Wanker EE; Doherty P; Davies SW; Bates GP
Hum Mol Genet; 1999 May; 8(5):813-22. PubMed ID: 10196370
[TBL] [Abstract][Full Text] [Related]
13. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA.
Reddy PH; Williams M; Charles V; Garrett L; Pike-Buchanan L; Whetsell WO; Miller G; Tagle DA
Nat Genet; 1998 Oct; 20(2):198-202. PubMed ID: 9771716
[TBL] [Abstract][Full Text] [Related]
14. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
Schilling G; Becher MW; Sharp AH; Jinnah HA; Duan K; Kotzuk JA; Slunt HH; Ratovitski T; Cooper JK; Jenkins NA; Copeland NG; Price DL; Ross CA; Borchelt DR
Hum Mol Genet; 1999 Mar; 8(3):397-407. PubMed ID: 9949199
[TBL] [Abstract][Full Text] [Related]
15. Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease.
Schiefer J; Landwehrmeyer GB; Lüesse HG; Sprünken A; Puls C; Milkereit A; Milkereit E; Kosinski CM
Mov Disord; 2002 Jul; 17(4):748-57. PubMed ID: 12210870
[TBL] [Abstract][Full Text] [Related]
16. The early cellular pathology of Huntington's disease.
Li XJ
Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117
[TBL] [Abstract][Full Text] [Related]
17. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
Mangiarini L; Sathasivam K; Seller M; Cozens B; Harper A; Hetherington C; Lawton M; Trottier Y; Lehrach H; Davies SW; Bates GP
Cell; 1996 Nov; 87(3):493-506. PubMed ID: 8898202
[TBL] [Abstract][Full Text] [Related]
18. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.
Menalled LB; Sison JD; Wu Y; Olivieri M; Li XJ; Li H; Zeitlin S; Chesselet MF
J Neurosci; 2002 Sep; 22(18):8266-76. PubMed ID: 12223581
[TBL] [Abstract][Full Text] [Related]
19. The selective vulnerability of nerve cells in Huntington's disease.
Sieradzan KA; Mann DM
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
[TBL] [Abstract][Full Text] [Related]
20. Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse.
Brown TB; Bogush AI; Ehrlich ME
Hum Mol Genet; 2008 Oct; 17(20):3095-104. PubMed ID: 18632688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]